These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33660889)
21. Diagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy. Cohen JL; Cohen G; Solish N; Murray CA Facial Plast Surg Clin North Am; 2007 Feb; 15(1):17-30, v-vi. PubMed ID: 17317552 [TBL] [Abstract][Full Text] [Related]
22. Palmoplantar hyperhidrosis: a therapeutic challenge. Thomas I; Brown J; Vafaie J; Schwartz RA Am Fam Physician; 2004 Mar; 69(5):1117-20. PubMed ID: 15023010 [TBL] [Abstract][Full Text] [Related]
23. Topical Treatment of Primary Focal Hyperhidrosis, Part 1. Zur E Int J Pharm Compd; 2019; 23(1):23-31. PubMed ID: 30668532 [TBL] [Abstract][Full Text] [Related]
26. Update on pediatric hyperhidrosis. Gordon JR; Hill SE Dermatol Ther; 2013; 26(6):452-61. PubMed ID: 24552408 [TBL] [Abstract][Full Text] [Related]
27. A new device for the treatment of hyperhidrosis by iontophoresis. Midtgaard K Br J Dermatol; 1986 Apr; 114(4):485-8. PubMed ID: 3964546 [TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin for hyperhidrosis of areas other than the axillae and palms/soles. Glaser DA; Galperin TA Dermatol Clin; 2014 Oct; 32(4):517-25. PubMed ID: 25152345 [TBL] [Abstract][Full Text] [Related]
29. The Treatment of Primary Focal Hyperhidrosis. Wechter T; Feldman SR; Taylor SL Skin Therapy Lett; 2019 Jan; 24(1):1-7. PubMed ID: 30817880 [TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin for hyperhidrosis: a review. Grunfeld A; Murray CA; Solish N Am J Clin Dermatol; 2009; 10(2):87-102. PubMed ID: 19222249 [TBL] [Abstract][Full Text] [Related]
31. Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study. Hebert AA; Glaser DA; Green L; Hull C; Cather J; Drew J; Gopalan R; Pariser DM Pediatr Dermatol; 2020 May; 37(3):490-497. PubMed ID: 32147881 [TBL] [Abstract][Full Text] [Related]
32. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials. Pariser DM; Hebert AA; Drew J; Quiring J; Gopalan R; Glaser DA Am J Clin Dermatol; 2019 Feb; 20(1):135-145. PubMed ID: 30378087 [TBL] [Abstract][Full Text] [Related]
33. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials. Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318 [TBL] [Abstract][Full Text] [Related]
34. Variables Affecting Delivery of Glycopyrronium Tosylate Through Human Skin In Vitro. Caserta F; Lenn J; Hofland H J Drugs Dermatol; 2020 Nov; 19(11):1080-1085. PubMed ID: 33196749 [TBL] [Abstract][Full Text] [Related]
35. [Tap water iontophoresis in the treatment of hyperhidrosis of the hands and feet]. Hölzle E; Pauli M; Braun-Falco O Hautarzt; 1984 Mar; 35(3):142-7. PubMed ID: 6715169 [TBL] [Abstract][Full Text] [Related]